[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100586591":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":76,"collaborators":7,"id":78,"slug":7,"hasResults":79,"nctId":80,"briefTitle":81,"officialTitle":81,"acronym":82,"eligibilityCriteria":83,"healthyVolunteers":79,"sex":84,"minAge":85,"maxAge":7,"enrollmentInfo":86,"targetDuration":7,"studyType":89,"phases":7,"briefSummary":90,"conditions":91,"keywords":7,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":102},{"fullName":5,"class":6},"Societe dEtude, de Recherche et de Fabrication","INDUSTRY",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Clinical department","CONTACT","+33472056010","clinical@serf.fr",[15,30,41,50,65],{"facility":16,"status":17,"city":18,"state":7,"zip":7,"country":19,"cosmosGeoPoint":20,"geoPoint":25,"contacts":26},"CHU Dijon","RECRUITING","Dijon","France",{"type":21,"coordinates":22},"Point",[23,24],5.01391,47.31344,{"lat":24,"lon":23},[27],{"name":28,"role":11,"phone":12,"phoneExt":7,"email":29},"Pr Baulot","clinical_serf@stryker.com",{"facility":31,"status":17,"city":32,"state":7,"zip":7,"country":19,"cosmosGeoPoint":33,"geoPoint":37,"contacts":38},"HCL Croix-Rousse","Lyon",{"type":21,"coordinates":34},[35,36],4.84789,45.74906,{"lat":36,"lon":35},[39],{"name":40,"role":11,"phone":12,"phoneExt":7,"email":29},"Pr Lustig",{"facility":42,"status":43,"city":32,"state":7,"zip":7,"country":19,"cosmosGeoPoint":44,"geoPoint":46,"contacts":47},"HCL Lyon Sud","NOT_YET_RECRUITING",{"type":21,"coordinates":45},[35,36],{"lat":36,"lon":35},[48],{"name":49,"role":11,"phone":12,"phoneExt":7,"email":29},"Pr Fessy",{"facility":51,"status":17,"city":52,"state":7,"zip":7,"country":19,"cosmosGeoPoint":53,"geoPoint":57,"contacts":58},"CHU Saint Etienne","Saint-Etienne",{"type":21,"coordinates":54},[55,56],4.39,45.43389,{"lat":56,"lon":55},[59,61,64],{"name":60,"role":11,"phone":12,"phoneExt":7,"email":29},"Pr Philippot",{"name":62,"role":63,"phone":7,"phoneExt":7,"email":7},"Pr Farizon","PRINCIPAL_INVESTIGATOR",{"name":60,"role":63,"phone":7,"phoneExt":7,"email":7},{"facility":66,"status":17,"city":67,"state":7,"zip":7,"country":19,"cosmosGeoPoint":68,"geoPoint":72,"contacts":73},"CHU Strasbourg","Strasbourg",{"type":21,"coordinates":69},[70,71],7.74553,48.58392,{"lat":71,"lon":70},[74],{"name":75,"role":11,"phone":12,"phoneExt":7,"email":29},"Pr Bonnomet",{"type":77,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100586591",false,"NCT06917365","Clinical Performance of XPEO-E Liner in SERF Dual-mobility Cups","2024-01-XPEO-E","Inclusion Criteria:\n\n* Male or female adults.\n* Patient that needs to be implanted with a SERF total hip prosthesis.\n* Patient responding to IFU requirement.\n* Patient affiliated to French social security.\n* Patient who has provided a dated and signed informed consent form.\n\nExclusion Criteria:\n\n* Patient protected by a French legal measure (under legal protection, guardianship or curatorship).\n* Patient unable of expressing consent, according to the investigator.\n* Patient deprived of liberty or hospitalized against his consent.\n* Pregnant or breastfeeding patient.\n* Patient presenting a contraindication to the implantation of medical devices according to the instructions for use.\n* Patient with a contraindication to radiographic follow-up.\n* Patient not being, a priori, capable of respecting the schedule of follow-up visits, according to the investigator.\n* Patient unable to complete a self-questionnaire, according to the investigator.","ALL","18 Years",{"count":87,"type":88},500,"ESTIMATED","OBSERVATIONAL","XPEO-E liner is CE marked under MDD 93\u002F42\u002FCEE by equivalency with CI E liner. No pertaining data on XPEO-E liner is yet available. However, clinical evaluation concludes on a reaching of performance and safety and compliance with essential requirements. This study intends to collect data on XPEO-E in order to allow a transit to MDR 2017\u002F745 (EU).\n\nXPEO-E liner is intended to be used with NOVAE cups and SERF femoral heads and Stems. XPEO-E liner will be used according to their CE marking. These devices are intended for hip replacements with the aim of improving quality of life and reducing pain by replacing a damaged joint.\n\nThe follow-up visits are established according to the current practice. Additional procedure will only consist on questionnaires that will be filled by the patient and\u002For the surgeons.",[92],"Total Hip Arthroplasty (THA)","2026-04-09",{"date":95,"type":96},"2026-04-13","ACTUAL",{"date":98,"type":96},"2025-10-27",{"date":100,"type":88},"2032-03-31",{"name":5,"class":6},5]